PointState Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-17,500
| Closed | -$3.84M | – | 120 |
|
|
2021
Q4 | $3.84M | Buy |
+17,500
| New | +$3.84M | 0.06% | 70 |
|
|
2021
Q3 | – | Sell |
-50,000
| Closed | -$10.1M | – | 150 |
|
|
2021
Q2 | $10.1M | Hold |
50,000
| – | – | 0.17% | 57 |
|
|
2021
Q1 | $10.7M | Buy |
50,000
+7,659
| +18% | +$1.65M | 0.21% | 62 |
|
|
2020
Q4 | $10M | Buy |
+42,341
| New | +$10M | 0.19% | 62 |
|
|
2020
Q2 | – | Sell |
-8,500
| Closed | -$2.02M | – | 104 |
|
|
2020
Q1 | $2.02M | Buy |
+8,500
| New | +$2.02M | 0.1% | 40 |
|
|
2019
Q3 | – | Sell |
-8,400
| Closed | -$1.54M | – | 126 |
|
|
2019
Q2 | $1.54M | Buy |
8,400
+5,700
| +211% | +$1.05M | 0.03% | 80 |
|
|
2019
Q1 | $497K | Buy |
+2,700
| New | +$497K | 0.01% | 103 |
|
|
2018
Q3 | – | Sell |
-779,200
| Closed | -$132M | – | 173 |
|
|
2018
Q2 | $132M | Buy |
779,200
+480,523
| +161% | +$81.7M | 1.5% | 21 |
|
|
2018
Q1 | $48.7M | Sell |
298,677
-275,613
| -48% | -$44.9M | 0.53% | 50 |
|
|
2017
Q4 | $86.1M | Buy |
574,290
+101,690
| +22% | +$15.2M | 0.84% | 35 |
|
|
2017
Q3 | $71.9M | Buy |
472,600
+391,300
| +481% | +$59.5M | 0.61% | 37 |
|
|
2017
Q2 | $10.5M | Sell |
81,300
-471,300
| -85% | -$60.7M | 0.11% | 77 |
|
|
2017
Q1 | $60.4M | Buy |
+552,600
| New | +$60.4M | 0.63% | 38 |
|
|
2015
Q4 | – | Sell |
-495,200
| Closed | -$51.6M | – | 102 |
|
|
2015
Q3 | $51.6M | Buy |
495,200
+345,200
| +230% | +$35.9M | 1.44% | 15 |
|
|
2015
Q2 | $18.5M | Buy |
+150,000
| New | +$18.5M | 0.22% | 62 |
|